Counterpart Health Expands Proven Flywheel for HEDIS Excellence to Third-Party Partners
Counterpart Health (CLOV) said its AI-driven HEDIS flywheel again powered Clover Health Medicare Advantage plans to top-tier results and made the platform available to third-party partners on Oct 14, 2025. Clover was the #1 performing PPO for HEDIS clinical quality measures among plans over 2,000 members and the only PPO in the Top 10. The flywheel combines point-of-care Counterpart Assistant prompts, real-time ingestion from 100+ data sources, NLP/LLM abstraction, and AI-augmented documentation closure to raise quality and reduce administrative burden.
Counterpart cites improved benchmark rates for screenings and diabetic eye exams and plans to scale the platform to more partners.
Counterpart Health (CLOV) ha dichiarato che il suo volano HEDIS guidato dall'IA ha nuovamente fornito risultati di alto livello alle assicurazioni Clover Health Medicare Advantage e ha reso la piattaforma disponibile a partner terzi il 14 ottobre 2025. Clover è stato il PPO più performante per le misure di qualità clinica HEDIS tra i piani con oltre 2.000 membri e l'unico PPO tra i Top 10. Il volano combina prompt di Counterpart Assistant a punto di cura, l'ingestione in tempo reale da più di 100 fonti di dati, astrazione NLP/LLM e chiusura della documentazione potenziata dall'IA per aumentare la qualità e ridurre l'onere amministrativo.
Counterpart cita tassi di riferimento migliorati per gli screening e per gli esami oculistici diabetici e prevede di ampliare la piattaforma a più partner.
Counterpart Health (CLOV) dijo que su volante HEDIS impulsado por IA volvió a impulsar los planes Clover Health Medicare Advantage hacia resultados de primer nivel y puso la plataforma a disposición de socios externos el 14 de octubre de 2025. Clover fue el PPO con mejor rendimiento en las medidas de calidad clínica de HEDIS entre planes con más de 2.000 miembros y el único PPO en el Top 10. El volante gira combina prompts de Counterpart Assistant en el punto de atención, ingesta en tiempo real de más de 100 fuentes de datos, abstracción NLP/LLM y cierre de documentación potenciado por IA para aumentar la calidad y reducir la carga administrativa.
Counterpart cita tasas de referencia mejoradas para cribados y exámenes oculares diabéticos y planea escalar la plataforma a más socios.
Counterpart Health (CLOV)의 AI 주도 HEDIS 플라이휠이 다시 Clover Health Medicare Advantage 계획을 최상위 결과로 이끌었고 2025년 10월 14일 제3자 파트너에게 플랫폼을 제공했다고 말했다. Clover는 HEDIS 임상의 질 지표에서 2,000명 이상의 계획 중에서 최고의 PPO였고 상위 10개 중 유일한 PPO였다. 이 플라이휠은 현장 즉시 Counterpart Assistant 프롬프트, 100개 이상의 데이터 소스에서의 실시간 수집, NLP/LLM 추상화, 그리고 AI가 보강한 문서 마감을 결합하여 품질을 높이고 행정 부담을 줄인다.
Counterpart는 검사 및 당뇨병성 망막검사에 대한 벤치마크 개선률을 인용하고 더 많은 파트너에게 플랫폼을 확장할 계획이라고 밝혔다.
Counterpart Health (CLOV) a déclaré que son volant HEDIS piloté par IA a à nouveau donné des résultats de premier ordre pour les plans Clover Health Medicare Advantage et a rendu la plateforme disponible à des partenaires tiers le 14 octobre 2025. Clover était le PPO n°1 en performance pour les mesures de qualité clinique HEDIS parmi les plans de plus de 2 000 membres et le seul PPO dans le Top 10. Le volant combine des invites Counterpart Assistant au point de care, une ingestion en temps réel de plus de 100 sources de données, une abstraction NLP/LLM et une clôture de documentation augmentée par l'IA pour améliorer la qualité et réduire la charge administrative.
Counterpart cite des taux de référence améliorés pour les dépistages et les examens oculaires diabétiques et prévoit d'étendre la plateforme à davantage de partenaires.
Counterpart Health (CLOV) sagte, dass sein KI-gesteuerter HEDIS-Impulsfasen erneut Clover Health Medicare Advantage-Pläne zu Ergebnissen der Spitzenklasse verholfen hat und die Plattform am 14. Oktober 2025 auch Drittpartnern zur Verfügung gestellt wurde. Clover war der #1-Performing PPO für HEDIS-Klinikqualitätsmaße unter Plänen mit mehr als 2.000 Mitgliedern und der einzige PPO in den Top 10. Der Impuls fasst Point-of-Care Counterpart Assistant-Eingaben, Echtzeit-Ingestion aus 100+ Datenquellen, NLP/LLM-Abstraktion und AI-unterstützte Dokumentationsabschlüsse zusammen, um die Qualität zu erhöhen und die administrative Belastung zu reduzieren.
Counterpart nennt verbesserte Benchmark-Raten für Screenings und diabetische Augenuntersuchungen und plant, die Plattform auf weitere Partner auszuweiten.
Counterpart Health (CLOV) قالت إن عجلة HEDIS المدفوعة بالذكاء الاصطناعي لديها دفعت مرة أخرى خطط Clover Health Medicare Advantage نحو نتائج من الطراز الأول وجعلت المنصة متاحة لشركاء الطرف الثالث في 14 أكتوبر 2025. كان Clover هو PPO الأكثر أداءً في مقاييس جودة HEDIS السريرية بين الخطط التي تضم أكثر من 2000 عضو وكان الوحيد PPO في العشرة الأوائل. تجمع العجلة بين موجهات Counterpart Assistant في نقطة الرعاية، وابتلاع البيانات في الوقت الفعلي من 100+ مصدر بيانات، والتجريد NLP/LLM، وإغلاق التوثيق المعزز بالذكاء الاصطناعي لرفع الجودة وتقليل العبء الإداري.
تشير Counterpart إلى معدلات معيارية محسنة للفحوصات والفحوصات العينية لمرضى السكري وتخطط لتوسيع المنصة إلى مزيد من الشركاء.
Counterpart Health (CLOV)表示其由AI驱动的HEDIS飞轮再次为Clover Health Medicare Advantage计划带来顶级结果，并于2025年10月14日向第三方合作伙伴开放平台。 Clover是在成员超过2000的计划中达到HEDIS临床质量指标的PPO中表现最好的之一，也是前十名中唯一的PPO。该飞轮结合现场点对点的Counterpart Assistant提示、来自100+数据源的实时摄取、NLP/LLM抽象，以及AI增强的文档完成，以提高质量并减少行政负担。
Counterpart提到筛查和糖尿病性眼科检查的基准率有所改善，计划将该平台扩展到更多合作伙伴。
- Clover ranked #1 PPO for HEDIS measures among plans >2,000 members
- Platform now offered to third-party partners, expanding addressable market
- Aggregates clinical data from 100+ sources for unified patient views
- None.
Insights
Counterpart opens its AI HEDIS platform to third parties, scaling a proven quality-improvement flywheel.
Counterpart Health operationalizes an AI-driven flywheel that combines point-of-care assistance, broad data ingestion, NLP/LLM abstraction, and AI-augmented documentation to close HEDIS clinical gaps. The company reports this stack again powered Clover Health to be the #1 performing PPO for HEDIS measures among plans over 2,000 members, and it is now offering the same platform to third-party partners as of
The value proposition rests on three linked capabilities: surfacing actionable gaps at the visit, capturing real‑time data from 100+ sources to build a unified patient view, and using AI to reduce abstraction and documentation burden. The biggest dependencies are partner data access and operational adoption by non-employed clinicians; without reliable data feeds or provider workflow integration, the flywheel cannot close gaps at scale.
Watch for three concrete items over the next 6–18 months: partner onboarding cadence and any named third‑party contracts, measured lift in HEDIS performance among external partners versus baseline, and evidence of data integrations from the claimed "100 data sources." These milestones will show whether the platform’s internal success replicates externally and when scale effects might appear.
Technology platform again powers top-tier HEDIS results for Clover Health Medicare Advantage plans
SAN FRANCISCO, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. (“Counterpart”), a wholly owned subsidiary of Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”) and a leading AI-powered value-based care enablement company, today announced that its technology platform has once again powered top-tier HEDIS results for Clover Health Medicare Advantage plans through its AI-driven flywheel. The company is now making this unparalleled HEDIS platform available to third-party partners for the first time.
As with last year, Counterpart has enabled Clover Health to be the #1 performing PPO plan in the country for HEDIS clinical quality measures for plans over 2,000 members. Clover is again the only PPO amongst the Top 10 plans, demonstrating our AI platform’s unique ability to drive both member outcomes and plan performance across a wide network of non-employed physicians, without capitation.
Counterpart Health’s flywheel for HEDIS excellence includes:
- CA-powered visits with clinical care gap closure: at the point of care, Counterpart Assistant (CA) surfaces actionable HEDIS clinical gaps for providers to close, whether by validating existing clinical evidence or ordering needed tests or referrals.
- Data ingestion: each CA visit triggers real-time clinical data collection from across the healthcare landscape, aggregating from more than 100 data sources to build a unified patient view.
- AI-powered HEDIS abstraction: Counterpart applies natural language processing (NLP) and large language model (LLM) technologies to identify suspect hits and exclusions for care coordination staff to review.
- HEDIS documentation gap closure: AI-augmented abstraction tooling closes documentation gaps across measures, allowing PCPs to focus on preventive care and clinical action rather than administrative tasks.
This flywheel consistently powers superior results for Clover’s Medicare Advantage population. From a patient outcomes perspective, those who see a CA-powered provider are more likely to meet quality benchmarks on a range of measures, including measures focused on colorectal cancer screening, breast cancer screening, and diabetic eye exams, as demonstrated in a previously published whitepaper.
“This recognition for the second year running reinforces what we know: our technology doesn’t just reduce administrative burden, it directly improves quality and outcomes,” said Conrad Wai, CEO of Counterpart Health. “By opening our HEDIS excellence flywheel to third-party partners, we’re enabling more organizations to benefit from the same proven processes that powered Clover’s industry-leading results.”
As Counterpart Health continues to expand its platform, the company is committed to scaling this model across more partners, driving better data, smarter AI, and higher-quality outcomes for value-based care at scale.
About Counterpart Health
Counterpart Health, a subsidiary of Clover Health Investments, Corp., or Clover Health, is a leading AI-powered physician enablement platform transforming care delivery. Born out of Clover Health as Clover Assistant, Counterpart Health’s flagship software platform, Counterpart Assistant, provides clinically intuitive insights that help clinicians better manage chronic conditions and deliver high-quality care. Counterpart Health extends this powerful data-driven technology platform beyond Clover Health’s Medicare Advantage plan, bringing its benefits to a wider audience to improve patient outcomes and reduce healthcare costs nationwide. Several published studies demonstrate the technology’s impact on Diabetes, Chronic Kidney Disease, Congestive Heart Failure, and Chronic Obstructive Pulmonary Disease management, and Clinical Quality.
Investor Relations:
Ryan Schmidt
Press Inquiries:
FAQ
What did Counterpart Health announce on Oct 14, 2025 about CLOV?
How did Clover (CLOV) rank in HEDIS clinical quality measures in 2025?
What components power Counterpart's HEDIS flywheel for CLOV?
What investor impact does Counterpart's platform availability to partners have for CLOV?
Which quality measures improved for patients seeing CA-powered providers?
How does Counterpart collect patient data for CLOV's HEDIS work?
